Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04292171 · ClinicalTrials.gov registry record · Early Phase 1
Gabapentin for Perioperative Pain Relief in Surgical Abortion
A Early Phase 1 study, sponsored by University of Nevada, Las Vegas.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 219
- Enrollment target
NCT04292171 is a Early Phase 1 study that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 219 participants.
The verdict
NCT04292171, a Early Phase 1 study, has completed, sponsored by University of Nevada, Las Vegas.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 219 participants
- Enrollment target
Study Summary
Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.
Interventions
- DRUG Placebos
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-03-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04292171
The ClinicalTrials.gov registry entry for NCT04292171 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nevada, Las Vegas, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebos is the first listed.
NCT04292171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04292171 about?
NCT04292171 is a clinical study titled "Gabapentin for Perioperative Pain Relief in Surgical Abortion". Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.
What is the current status of trial NCT04292171?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 219 participants. The study started on 2017-05-01. Estimated completion is 2018-03-30.
What interventions are being tested in trial NCT04292171?
The interventions under investigation include: Placebos (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT04292171?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.